// App-Quantinova.ai

P-612 : Current understanding of polycystic ovary syndrome (PCOS and potential interest in future trial to evaluate role of myo-inositol as ovulation induction agent – Stakeholder’s surveys

Researchers

Presenter

  • J Pundir

Principal Investigators

  • E Dimitriou

  • S Thangaratinam

Medical Centers

  • National and Kapodistrian University of Athens, 1st Department of Internal Medicine, Medical School, Athens, Greece

  • St Bartholomew's Hospital, Centre of Reproductive Medicine, London, United Kingdom

  • Institute of Metabolism and Systems Research University of Birmingham, University of Birmingham- Edgbaston- Birmingham, Birmingham, United Kingdom

Locations

  • Greece

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Obstetrics/Gynecology

Disease

  • Polycystic Ovary Syndrome

  • Gestational Diabetes

  • Diabetes

Biomarkers

  • Myo-inositol

Drug/Treatment

  • Inositol

  • clomiphene

  • Metformin Hydrochloride

  • Letrozole

  • Clomid

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved